AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the second quarter of 2024 when its
Categories
Health Care
Walgreens Boots Alliance (WBA) Q1 2024 profit and sales beat estimates
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) on Thursday reported stronger-than-expected earnings and revenues for the first quarter of 2024. Net profit, on
Walgreens (WBA) to report Q1 results on Thursday. Here’s what to expect
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) is scheduled to report first-quarter earnings on Thursday, amid expectations for a mixed outcome. The retail
Earnings Summary: Highlights of CooperCompanies’ (COO) Q4 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the fourth quarter of 2023, reporting an increase in revenues and adjusted
Ocean Biomedical’s breast cancer research uncovers new tumor suppression pathway for its proprietary antibody
Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said that new findings, co-authored by the company’s scientific co-founder Jack A. Elias
Johnson & Johnson (JNJ) focuses on innovation after separating consumer business
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) recently raised its full-year guidance to reflect the strong performance of the pharmaceutical and medical
Agilent Technologies (A) Earnings: 4Q23 Key Numbers
Agilent Technologies Inc. (NYSE: A) reported revenue of $1.69 billion for the fourth quarter of 2023, down 8.7% on a reported basis
Medtronic (MDT) Q2 2024 adj. earnings decline despite revenue growth
Medical device maker Medtronic plc (NYSE: MDT) reported a decline in adjusted earnings for the second quarter of 2024, despite an increase
Earnings Summary: Highlights of Catalent’s Q1 2024 results
Catalent, Inc. (NYSE: CTLT), a provider of delivery technologies and development solutions to the pharmaceutical industry, has reported earnings for the first
Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary
Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biotechnology company focused on transforming biomedical inventions into cutting-edge therapies. The company develops novel therapies
Ocean Biomedical’s JV partner Virion presents positive oncology data at SITC 2023
Ocean Biomedical, Inc. (NASDAQ: OCEA), a biotechnology company that works to accelerate the development and commercialization of discoveries from research universities and
Earnings Summary: Henry Schein (HSIC) Q3 2023 financial results
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, reported financial results for the third quarter
Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary
Trxade Health, Inc. (NASDAQ: MEDS) is a leading health service IT company that operates a pharmaceutical business-to-business exchange platform. As part of
Earnings Summary: Becton, Dickinson, and Company reports Q4 2023 results
Medical technology company Becton, Dickinson, and Company (NYSE: BDX) announced results for the final three months of fiscal 2023. Fourth-quarter revenue increased
Earnings Summary: Highlights of Charles River Laboratories’ Q3 2023 results
Pharma company Charles River Laboratories International, Inc. (NYSE: CRL) on Wednesday reported financial results for the third quarter of 2023. Revenue was
Biogen (BIIB) Q3 2023 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported third quarter 2023 earnings results today. Total revenue rose 1% year-over-year to $2.53 billion. Revenues grew 3%
Gilead Sciences reports Q3 earnings. Here’s everything you need to know
Gilead Sciences, Inc. (NASDAQ: GILD), a leading research-based biopharmaceutical company, on Tuesday reported financial results for the third quarter of 2023. Revenues
Earnings Summary: A snapshot of Zimmer Biomet Holdings’ Q3 2023 results
Medical technology company Zimmer Biomet Holdings, Inc. (NYSE: ZBH) on Tuesday reported an increase in third-quarter sales and adjusted profit. Third-quarter net
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also
Earnings Summary: Highlights of IDEXX Laboratories’ Q3 2023 earnings
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, has reported financial results for the third quarter of 2023. The
REGN Earnings: Regeneron Pharma Q3 revenue, adj. profit increase
Healthcare firm Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported an increase in adjusted earnings and revenues for the third quarter of